On June 24, a day before Genometrix closed its doors, founder and chief executive officer Mitch Eggers resigned from the Woodlands, TX-based microarray services and gene expression software company to start a new genomics company.

Eggers said initial venture capital financing for the company will be completed within 60 to 90 days. The company will involve former employees of Genometrix, which ran out of cash in late June after canceling its initial public offering in March.